title: Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions.
authors.affiliation: Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology, and Clinical Chemistry, University of Tübingen, Tübingen, Germany.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Kantartzis
authors.forename: Kilian
authors.initials: K
authors.lastname: Rittig
authors.forename: Alexander
authors.initials: A
authors.lastname: Cegan
authors.forename: Jürgen
authors.initials: J
authors.lastname: Machann
authors.forename: Fritz
authors.initials: F
authors.lastname: Schick
authors.forename: Bernd
authors.initials: B
authors.lastname: Balletshofer
authors.forename: Andreas
authors.initials: A
authors.lastname: Fritsche
authors.forename: Erwin
authors.initials: E
authors.lastname: Schleicher
authors.forename: Hans-Ulrich
authors.initials: HU
authors.lastname: Häring
authors.forename: Norbert
authors.initials: N
authors.lastname: Stefan
mesh_terms: D052242:Adiponectin / Q000097:blood; D001053:Apolipoproteins / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D005234:Fatty Liver / Q000097:blood* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D053439:Lipoproteins, HDL2 / Q000097:blood*; D053440:Lipoproteins, HDL3 / Q000097:blood*; D008297:Male; D012016:Reference Values; D012307:Risk Factors
chemical_list: D052242:Adiponectin; D001053:Apolipoproteins; D053439:Lipoproteins, HDL2; D053440:Lipoproteins, HDL3